Welcome to our dedicated page for PetIQ news (Ticker: PETQ), a resource for investors and traders seeking the latest updates and insights on PetIQ stock.
PetIQ, Inc. (NASDAQ: PETQ) is a leading innovator in pet medication and wellness based in Eagle, Idaho. Founded with a mission to enhance the lives of pets by providing veterinarian-recommended products, PetIQ offers a diverse portfolio of pet health solutions. The company’s offerings include prescription medications, over-the-counter flea and tick preventatives, health and wellness supplements, and various treats for both dogs and cats.
PetIQ operates through two primary segments: Products and Services. The Products segment, which generates the majority of the company's revenue, features a range of proprietary brands including Minties®, Advecta®, PetAction®, VetIQ®, Delightibles®, and Betsy Farms®. These products are available nationwide through traditional retail and e-commerce channels, making quality pet care accessible and affordable.
The Services segment offers veterinary services through community clinics and wellness centers in over 2,600 retail partner locations across 41 states. This extensive reach ensures that pet owners can conveniently access essential veterinary care.
Recent financial results indicate robust growth and strategic progress. In the third quarter of 2023, PetIQ reported a 32.1% increase in net sales to $277.0 million compared to the prior year period. The Products segment experienced a 36.0% rise in net sales, driven by broad-based growth across product categories and sales channels. The company’s strategic acquisition of Rocco & Roxie LLC also contributed to the impressive performance. Gross profit surged by 43.0%, reflecting improved manufacturing efficiencies and a favorable product mix.
PetIQ has made significant strides in operational efficiency and financial health. The company's net leverage was reduced to a record low of 2.8x by the end of the third quarter of 2023, demonstrating strong cash generation and disciplined financial management.
Looking ahead, PetIQ aims to further enhance its market presence and operational capabilities. The company is optimizing its Services segment by closing underperforming wellness centers and investing in areas with high returns, such as mobile community clinics and strategic marketing initiatives for its manufactured brands.
For investors and stakeholders, PetIQ represents a dynamic and growing player in the pet care industry, committed to innovation, quality, and accessibility. For more detailed financial information and updates, visit PetIQ.com.
PetIQ, a leader in pet medication and wellness, will participate in the Raymond James 42nd Annual Institutional Investors Conference on March 3, 2021, at 3:00 p.m. EST. The event will be accessible live on the Company’s website. PetIQ offers affordable veterinary products through over 60,000 distribution points and operates the VIP Petcare service platform in over 3,400 locations across 41 states. The Company emphasizes its commitment to delivering quality care and products for pets, reflecting its belief in treating pets as family.
EAGLE, Idaho, Feb. 11, 2021 – PetIQ, a leading pet medication and wellness company (Nasdaq: PETQ), will report its fourth quarter and full year results for 2020 on February 25, 2021, after market close. A conference call hosted by the executive management team will follow at 4:30 p.m. ET the same day, with participation available via phone or live broadcast on the Company’s website. A playback of the call will be accessible until March 11, 2021. PetIQ emphasizes affordable veterinary products through over 60,000 distribution points and operates VIP Petcare in 41 states.
PetIQ (Nasdaq: PETQ), a leading pet medication and wellness company, announced its participation in the Jefferies Virtual West Coast Consumer Conference. The management fireside chat is scheduled for November 17, 2020, at 12:20 p.m. ET. The event can be accessed live on the company’s website under the 'Investors' section.
PetIQ offers a smarter way for pet parents to care for their pets through affordable veterinary products. With over 60,000 distribution points and a national service platform, VIP Petcare, operating in 41 states, the company is committed to enhancing pet wellness.
PetIQ, a pet medication and wellness company, reported its Q3 2020 financial results, showing net sales of $162.1 million, a 12.9% decline from the previous year. Despite a strong year-to-date sales growth of 10.9%, the Services segment faced a significant 51.7% revenue drop to $12.0 million. The net loss increased to $64.5 million, primarily due to a non-cash tax expense. The Company completed the acquisition of Capstar, expecting over $20 million in incremental EBITDA in 2021. Total liquidity stands at approximately $167 million as of September 30, 2020.
PetIQ, a prominent pet medication and wellness company, will announce its third-quarter financial results on November 5, 2020, after the market closes. The company's executive management will host a conference call at 4:30 p.m. ET on the same day to discuss these results. Interested parties can participate by calling designated numbers or by accessing the live broadcast on PetIQ's website. A playback of the call will be available until November 19, 2020. PetIQ serves over 60,000 distribution points and operates a national service platform providing affordable veterinary services.
PetIQ has successfully re-opened approximately 70% of its wellness centers and 60% of its community clinics, with all 37 regional offices now operational. The company aims to re-open 95% of its clinics by the end of Q3 2020. Additionally, 27 new wellness centers under construction are expected to debut in Q4 2020. Recent openings have shown a quick recovery in customer traffic, returning to pre-COVID-19 levels. CEO Cord Christensen expressed optimism about PetIQ’s ability to meet the increasing demand for affordable veterinary care.
PetIQ, Inc. (Nasdaq: PETQ) announced the acquisition of the Capstar® portfolio, effective July 31, 2020. Capstar® is the leading oral OTC flea treatment in the U.S., contributing to PetIQ's strategy to provide affordable pet health solutions. The acquisition includes seven SKUs, solidifying PetIQ's market presence, especially as Capstar® remains the only oral OTC flea treatment for cats. CEO Cord Christensen highlighted the acquisition’s profitability and growth potential, reinforcing PetIQ’s commitment to enhancing pet wellness.
PetIQ, a prominent pet medication and wellness company, will release its second-quarter financial results for the period ending June 30, 2020, on August 6, 2020, post market close. The conference call to discuss these results will commence at 4:30 p.m. ET, accessible via phone for North American listeners at 855-327-6837 and for international listeners at 631-891-4304. The call will also be streamed live on PetIQ's website. A playback will be available until August 27, 2020, with specific dial-in details provided.
PetIQ, a prominent pet medication and wellness company, will participate in the Jefferies Virtual Consumer Conference on June 23, 2020, at 10:30 a.m. ET. The event will be accessible live via the Company's website. PetIQ aims to improve pet health through affordable veterinary products and services, distributed via over 60,000 retail and e-commerce points. Their national service platform, VIP Petcare, offers services in 41 states, underscoring the Company's commitment to pet wellness.
PetIQ, a premier pet medication and wellness company, announced its participation in the 40th Annual William Blair Growth Stock Conference. The management team will engage in a fireside chat on June 11, 2020, at 8:00 a.m. CT, accessible via the Investors section on www.PetIQ.com.
PetIQ operates over 60,000 distribution points and offers affordable veterinary products through its national service platform, VIP Petcare, in 41 states. The company emphasizes quality pet care and services, reflecting its commitment to pet wellness.
FAQ
What is the current stock price of PetIQ (PETQ)?
What is the market cap of PetIQ (PETQ)?
What products does PetIQ offer?
Where are PetIQ products available?
What are the main segments of PetIQ's business?
How did PetIQ perform financially in recent quarters?
What strategic initiatives has PetIQ undertaken?
Where is PetIQ headquartered?
What partnerships does PetIQ have?
What are some of PetIQ's proprietary brands?
How does PetIQ ensure accessibility to pet care products?
What is PetIQ's outlook for future growth?
